Here's how to use BPC-157: reconstitution, dosing, injection technique, and cycle structure explained step by step. BPC-157 is a compounded peptide, not FDA-approved, and all protocols are subject to medical approval by a licensed provider at TelosRX.
BPC-157 (Body Protection Compound-157) is not FDA-approved for any medical use. What follows is an educational walkthrough of how supervised protocols are typically structured, to help you know what to expect and what questions to ask your provider. Nothing here substitutes for a provider-issued prescription and written dosing instructions specific to your vial and protocol.
Step 1: Get a Provider-Issued Prescription and Written Protocol
You cannot legally obtain pharmaceutical-grade, compounded BPC-157 without a prescription from a licensed provider. This step is non-optional — and it's also the step that makes the rest of the protocol safer.
A prescribing provider evaluates your medical history, the injury or condition you're targeting, current medications, and whether BPC-157 is appropriate. They issue written instructions that include your specific vial size, reconstitution volume, dose in micrograms, injection frequency, and cycle length.
Those written instructions override anything generic you read online. They're specific to your vial's concentration — which varies by compounding pharmacy.
TelosRX evaluates peptide candidates asynchronously — no scheduled phone calls, no waiting. See the BPC-157 patient guide for background on the compound before starting an evaluation.
Step 2: Gather Your Supplies
Before reconstitution, confirm you have everything on this list:
- BPC-157 lyophilized vial (the white powder)
- Bacteriostatic water (BAC water — not plain sterile water; BAC water stays sterile for 28 days after opening)
- Insulin syringes, 29–31 gauge, 0.3–1 mL
- Alcohol swabs
- Sharps disposal container
- A permanent marker to date your reconstituted vial
Do not use plain sterile water. It has a 24-hour window after opening. BAC water gives you up to 28 days with a reconstituted vial stored correctly.
Step 3: Reconstitute Your BPC-157 Vial
This is the most technique-sensitive step. Do it carefully once and you'll never think about it again.
- Allow both vials to reach room temperature. Cold powder hydrates slowly and may appear undissolved.
- Wipe both stoppers with a fresh alcohol swab. Let dry for 10 seconds before puncturing.
- Draw the prescribed volume of BAC water into your syringe. Remove any air bubbles.
- Insert the needle at an angle and aim the water stream down the inside glass wall of the BPC-157 vial — not directly onto the powder.
- Swirl gently. Roll the vial between your fingers for 30–60 seconds. Do not shake. Shaking introduces air bubbles and can denature the peptide.
- Inspect the solution. It should be clear and colorless. Cloudiness or particles mean reconstitution failed — do not inject.
- Label the vial with today's date. Use within 28 days, stored refrigerated.
BPC-157 Reconstitution Reference Table
| Vial Size | BAC Water Added | Resulting Concentration | 250 mcg dose = how many units (U-100 syringe) |
|---|---|---|---|
| 5 mg (5,000 mcg) | 2 mL | 2,500 mcg/mL | 10 units |
| 5 mg (5,000 mcg) | 5 mL | 1,000 mcg/mL | 25 units |
| 10 mg (10,000 mcg) | 2 mL | 5,000 mcg/mL | 5 units |
Always follow your provider's written instructions for your specific vial. These are reference figures only.
Step 4: Calculate Your Dose
Your prescribing provider gives you the exact number of units to draw per dose based on your vial size and reconstitution volume. The general formula: divide your target dose in mcg by the concentration in mcg/mL, then multiply by 100 to get units on a U-100 syringe.
Reported research protocols commonly use 250–500 mcg once or twice daily for 4–6 weeks, though no FDA-approved dosing standard exists. Your prescribed dose may differ — follow written instructions from your provider, not general online references.
Step 5: Prepare and Administer the Injection
BPC-157 is most commonly administered subcutaneously — into the fat layer just beneath the skin.
- Wash hands thoroughly or use gloves.
- Wipe the vial stopper with an alcohol swab.
- Draw your prescribed units into the syringe. Tap out air bubbles.
- Clean the injection site with an alcohol swab. Let it dry.
- Pinch 1–2 cm of skin between thumb and forefinger.
- Insert the needle at 45 degrees into the pinched skin fold.
- Depress the plunger slowly and steadily.
- Withdraw the needle and apply light pressure. Do not rub.
- Dispose of the needle in your sharps container immediately.
All injection steps are subject to provider-issued guidance. Your provider may specify modified technique based on your anatomy or injection site.
Step 6: Choose Your Injection Site
For systemic effects (gut healing, general recovery), the lower abdomen — 2 inches from the navel — is the standard subcutaneous site. Rotate quadrants with each injection to prevent lipodystrophy.
For localized injury recovery, preclinical research supports injecting within 1–3 cm of the injured structure. A 2025 systematic review of 36 studies confirmed BPC-157 improved structural and biomechanical outcomes in tendon, ligament, and muscle injury models — with local administration showing the strongest tissue effects. (PMC12313605)
Never inject directly into a tendon. Inject subcutaneously alongside it — within 1–3 cm.
Explore how BPC-157 compares to TB-500 for tendon repair if you're deciding between or considering stacking them.
Step 7: Follow Your Cycle Schedule
Most supervised protocols run 4–6 weeks on, followed by 2–4 weeks off. The off-period allows the body to reset before a subsequent cycle, though long-term safety data in humans remains limited. All cycle decisions are subject to medical approval by a licensed provider.
| Phase | Duration | Frequency | Notes |
|---|---|---|---|
| Active cycle | 4–6 weeks | Daily or 5×/week | Follow provider-issued protocol |
| Off period | 2–4 weeks | None | Allow tissue reset |
| Subsequent cycle | Per provider | Per provider | Reassess with provider first |
Step 8: Monitor Response and Adjust
Track your target outcome — pain, range of motion, function, gut symptoms — at weekly intervals. Injections site reactions (mild redness, swelling) are the most commonly reported side effects in practice. Fatigue and nausea occur less frequently.
Send a progress message through the TelosRX asynchronous platform at your week-four check-in. Dose adjustments, cycle extensions, or stacking decisions (e.g., adding TB-500 for synergistic tissue repair) are made at that point — with your provider, not independently.
Early research findings on BPC-157's tendon healing mechanisms are promising. A foundational 2003 study by Staresinic et al. showed accelerated Achilles tendon repair in rat models, with improved structural integrity and reduced inflammatory infiltrates. (Pubmed 14554191) Human trials remain limited — framing protocols as investigational is accurate and important.
Frequently Asked Questions
How long does BPC-157 take to work?
People typically report initial changes in pain, range of motion, or GI symptoms within 2–4 weeks of a daily protocol. Full cycle response is generally assessed at 4–6 weeks. Timeline depends on the type and severity of the injury, activity level, and other concurrent care. No guaranteed timeline exists.
What is the standard BPC-157 dose?
No FDA-approved dosing standard exists for compounded BPC-157. Reported protocols commonly cite 250–500 mcg once or twice daily for 4–6 weeks via subcutaneous injection. Your prescribing provider sets the dose specific to your vial concentration and clinical situation.
Can I use BPC-157 without a prescription?
BPC-157 compounded for human use requires a prescription from a licensed provider. Using unregulated research-grade peptides without medical supervision carries unknown purity, sterility, and safety risks. TelosRX evaluates candidates asynchronously and, if approved, ships pharmacy-compounded product directly to you.
How do I store reconstituted BPC-157?
Store reconstituted BPC-157 refrigerated (36–46°F / 2–8°C), protected from light. Use within 28 days of reconstitution when bacteriostatic water is used. Do not freeze reconstituted solution — freeze-thaw cycles degrade peptide stability. Label every vial with the date reconstituted.
Can BPC-157 be taken orally instead of injected?
Oral and sublingual forms of BPC-157 exist and are used in some protocols, particularly for GI tract conditions where direct mucosal contact may be beneficial. BPC-157 is relatively stable in gastric acid. However, most recovery and repair protocols use subcutaneous injection for systemic and local delivery. Your provider determines the appropriate route.
What is the difference between BPC-157 and TB-500?
BPC-157 (pentadecapeptide) is studied primarily for local tissue repair — tendons, ligaments, gut. TB-500 (Thymosin Beta-4 fragment) is studied for cell migration, systemic soft-tissue recovery, and anti-inflammatory signaling. They're often stacked in injury recovery protocols for potentially complementary mechanisms. Both are not FDA-approved compounded peptides, subject to provider evaluation.
TelosRX is LegitScript-certified. Compounded medications are not FDA-approved and are prepared under federal compounding regulations. Approval is subject to evaluation by a licensed provider; approval is not guaranteed. Individual results vary. TelosRX operates as an online-first, asynchronous telehealth service.
Start your private evaluation at TelosRX.